Back to search results

NaviCam Patency Capsule for Gastrointestinal Patency

This study is testing a device called the NaviCam Patency Capsule. This capsule helps doctors check if your digestive tract (gastrointestinal tract) is clear before you have another procedure called capsule endoscopy. You might be able to join if you are between 22 and "None" years old and have a known or suspected intestinal stricture (a narrowing of the intestine), Crohn's disease, or abdominal pain from long-term use of certain pain relievers (NSAIDs). The study aims to see how safe and effective the patency capsule is within 30 hours. The current recruitment status is unclear, and the study plans to enroll 25 participants.

Study design
This is an interventional study with a planned enrollment of 25 participants. The study does not specify a phase.
What's involved
You would swallow a patency capsule and then have an abdominal X-ray scan within 30 hours to see if the capsule is still in your body.
Compensation
Not stated in the trial record.
Follow-up
The safety and efficacy of the patency capsule are measured at 30 hours.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07649720

NaviCam Patency Capsule to Verify Gastrointestinal Patency

Not Yet Recruiting
NAAges 22+InterventionalScreening
AnX Robotica Corp.
~25 participants
Updated 2026-06-16 on ClinicalTrials.gov
What's tested:NaviCam Patency Capsule

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Safety of patency capsule
Measured over 30 hours
+1 more outcome measured

Conditions

Intestinal Stricture
Crohn Disease
NSAID (Non-Steroidal Anti-Inflammatory Drug) Induced Enteropathy
Abdominal Pain

Explore related trials

Chronic inflammatory disorderCrohn DiseaseIntestinal StrictureNSAID-Induced Nephropathy

Where it's being run

1 sites across 1 states
Illinois1

Study leadership

  • Rockford G Yapp, MD · PRINCIPAL_INVESTIGATOR · Digestive Health Services

Who to contact

Tim Thomas, RAC
[email protected]
770-480-2911
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Patients with suspected or known intestinal stricture (with medical history records, physical examination records, and imaging evidence within the last 6 months.
Patients suffering from Crohn's Disease
Patients with long-term use of non-steroidal anti-inflammatory drugs.
Patients with abdominal symptoms related to intestinal stricture.
Patients with chronic inflammatory diseases.
Patients with difficulty with balloon-assisted endoscopy (BAE).
Patients with a history of small bowel obstruction.
Patients with a history of intestinal resection surgery.

Exclusion

Patients with esophageal obstruction or swallowing disorder diseases.
Patients who are ineligible for surgery or refuse to undergo any abdominal surgery.
Patients with known allergies or other contraindications or intolerance to the medications used in this study.
Patients with pacemakers or other implanted electronic devices such as cochlear implants, magnetic metal drug infusion pumps, neurostimulators.
Pregnant women
Patients currently enrolled in another drug or device clinical trial.
Other conditions deemed unsuitable for inclusion by the investigator.

What this trial measures

  • Safety of patency capsule30 hours

    The number of patients successfully passing the Patency Capsule within 30 hours compared to the number of patients where the Patency Capsule dissolves in patients with strictures.

  • Efficacy of patency capsule30 hours

    The percentage of patients that successfully pass the Patency capsule within 30 hours.